Review

VIMTA LABS LTD.

Ticker : 524394  
FV: Rs 2
52-Week H/L: Rs 405.25/143.80

We recommended Vimta Labs Ltd in volume no. 38, issue no. 03 (dated November 08, 2021) when the scrip was trading at Rs 353.5. On the consolidated quarterly front, the company recorded an increase of 27.14 per cent in the net sales and operating income, which stood at Rs 75.5 crore for Q2FY22 as compared to the net sales & operating income of Rs 59.38 crore reported for Q2FY21. The quarter recorded an operating profit of Rs 20.07 crore in Q2FY22 as compared to the operating profit of Rs 16.03 crore posted in Q2FY21. The company reported a net profit of Rs 9.74 crore in Q2FY22 whereas, it was Rs 7.54 crore in Q2FY21. The stock has zoomed decently over the last six months and is trading near its 52-week high price. Hence, we recommend our investor-readers to BOOK PROFIT at Rs 398.95 with a gain of 12.85 per cent.